Authors:
Paoletti, LC
Peterson, DL
Legmann, R
Collier, RJ
Citation: Lc. Paoletti et al., Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen, VACCINE, 20(3-4), 2001, pp. 370-376
Citation: G. Malin et Lc. Paoletti, Use of a dynamic in vitro attachment and invasion system (DIVAS) to determine influence of growth rate on invasion of respiratory epithelial cells bygroup B Streptococcus, P NAS US, 98(23), 2001, pp. 13335-13340
Authors:
Paoletti, LC
Rench, MA
Kasper, DL
Molrine, D
Ambrosino, D
Baker, CJ
Citation: Lc. Paoletti et al., Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines, INFEC IMMUN, 69(11), 2001, pp. 6696-6701
Authors:
Baker, CJ
Paoletti, LC
Rench, MA
Guttormsen, HK
Carey, VJ
Hickman, ME
Kasper, DL
Citation: Cj. Baker et al., Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women, J INFEC DIS, 182(4), 2000, pp. 1129-1138
Citation: Lc. Paoletti et al., Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate, J INFEC DIS, 181(2), 2000, pp. 653-658
Citation: Lj. Paoletti et al., A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts, J CLIN MICR, 37(11), 1999, pp. 3759-3760
Authors:
Paoletti, LC
Pinel, J
Johnson, KD
Reinap, B
Ross, RA
Kasper, DL
Citation: Lc. Paoletti et al., Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII, J INFEC DIS, 180(3), 1999, pp. 892-895
Authors:
Lachenauer, CS
Kasper, DL
Shimada, J
Ichiman, Y
Ohtsuka, H
Kaku, M
Paoletti, LC
Ferrieri, P
Madoff, LC
Citation: Cs. Lachenauer et al., Serotypes VI and VIII predominate among group B streptococci isolated frompregnant Japanese women, J INFEC DIS, 179(4), 1999, pp. 1030-1033
Authors:
Baker, CJ
Paoletti, LC
Wessels, MR
Guttormsen, HK
Rench, MA
Hickman, ME
Kasper, DL
Citation: Cj. Baker et al., Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib, J INFEC DIS, 179(1), 1999, pp. 142-150
Authors:
Gravekamp, C
Kasper, DL
Paoletti, LC
Madoff, LC
Citation: C. Gravekamp et al., Alpha C protein as a carrier for type III capsular polysaccharide and as aprotective protein in group B streptococcal vaccines, INFEC IMMUN, 67(5), 1999, pp. 2491-2496
Authors:
Davies, JK
Paoletti, LC
McDuffie, RS
Madoff, LC
Lee, S
Eskens, J
Gibbs, RS
Citation: Jk. Davies et al., A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection, AM J OBST G, 181(4), 1999, pp. 803-808